A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Clinical trial NCT05515406 · TERMINATED

Trial details

NCT number: NCT05515406
Sponsor: Ono Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Leukemia, Lymphocytic, Chronic, B-Cell

Start date: 2023-02-13
Primary completion: 2025-08-13
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.